Request Study Information

After you submit your request, a staff member will contact you.There’s no obligation and our team is here to help you decide on a study that’s best for you.

A Multicenter, Randomized, Double-blind, Sham-controlled Study for Assessing the Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes (ReCET Study)

This study explores a new endoscopic procedure to help manage type 2 diabetes in people whose condition isn’t well-controlled with current non-insulin medications. Researchers aim to determine whether this therapy is safe and effective in improving blood sugar levels. Participants must meet specific health criteria and be willing to follow study requirements, including certain medication restrictions and preparation for procedures.

Eligibility:

• Ages 22–70
• Diagnosed with Type 2 Diabetes
• Not currently using insulin

Enter Your Information

(All fields are required)

Study Request Form (specific)

Name(Required)
Date of Birth(Required)
Race(Required)
Select one or more options that best describe you. This information can help ensure that all populations are represented in research.

By entering your email address and/or phone number on this form, you represent that you are at least 18 years of age and consent to receiving communications (e.g., call, SMS, text, and/or email) from ECIR and/or the research site(s) involved with the clinical trials that appear on this website. Messaging frequency varies. Message and data rates may apply. You may reply with STOP to a text message. For any help regarding messaging, please email us at [email protected]. For full details, refer to ECIR’s privacy policy and website terms of use. Submissions on this website are not monitored 24/7. Do NOT submit personal health or medical information on this form. If you are enrolled in a trial and have questions, please call your research site.